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Introduction
Cryptosporidiosis is the fifth leading cause of diarrhoeal 
mortality worldwide and caused more than 48 000 deaths 
and led to a loss of 12·9 million disability-adjusted life-
years in 2016, with the highest burden in sub-Saharan 
Africa.1 The disease ranked among the top five causes of 
diarrhoea in the Global Enteric Multicenter Study in 
2007–11,2,3 and has probably increased in relative impor-
tance since the rotavirus vaccine was rolled out globally.4 
There is no vaccine against Cryptosporidium species and 
the only approved drug, nitazoxanide, has moderate effect 
on diarrhoea and parasite clearance; although the drug 
significantly reduced mortality in one trial, it is not 
effective in children with HIV.5 Increased effort has been 
put into developing better drugs for cryptosporidiosis,6 
but a test-and-treat strategy will require a rapid, low-
technology, reliable, and affordable diagnostic test that can 
be used near the point of care, and that is suitable for use 
in low-resource settings.7 Diagnostic accuracy evaluations 
that are not done in the relevant clinical setting over-
estimate diagnostic accuracy and field applicability.8 We 
identified only one study from east Africa that evaluated 
immuno chromatographic lateral-flow assays (ICLFs) in 
children with complicated severe acute malnutrition, 
reporting moderate sensitivity against PCR results,9 and 
a Turkish study that evaluated modified Ziehl-Neelsen 
Performance and operational feasibility of two diagnostic 
tests for cryptosporidiosis in children (CRYPTO-POC): 
a clinical, prospective, diagnostic accuracy study
Øystein H Johansen, Alemseged Abdissa, Mike Zangenberg, Zeleke Mekonnen, Beza Eshetu, Ola Bjørang, Yonas Alemu, Bizuwarek Sharew, 
Nina Langeland, Lucy J Robertson, Kurt Hanevik
Summary
Background Cryptosporidiosis is a common cause of diarrhoea in young children (aged younger than 24 months) in 
low-resource settings but is currently challenging to diagnose. Light-emitting diode fluorescence microscopy with 
auramine-phenol staining (LED-AP), recommended for tuberculosis testing, can also detect Cryptosporidium species. 
A lateral-flow test not requiring refrigerator storage (by contrast with most immunochromatographic lateral-flow 
assays) has also recently been developed for Cryptosporidium spp detection. We aimed to evaluate the diagnostic 
accuracy and operational feasibility of LED-AP and the lateral-flow test strip for cryptosporidiosis in children.
Methods We did a prospective diagnostic accuracy study in two health-care facilities in Ethiopia, in a consecutive series 
of children younger than 5 years of age with diarrhoea (three or more loose stools within the previous 24 h) or dysentery 
(at least one loose stool with stains of blood within the previous 24 h). Stool samples were tested for Cryptosporidium 
spp by LED-AP and the lateral-flow test strip; accuracy of each test was estimated by independent and blind comparison 
with a composite reference standard comprising quantitative immunofluorescent antibody test (qIFAT), ELISA, and 
quantitative PCR (qPCR). Quantitative cutoff values for diarrhoea-associated infection were established in an embedded 
case-control substudy, with cases of cryptosporidiosis coming from the 15 districts in and around Jimma and the 
eight districts surrounding Serbo, and community controls without diarrhoea in the previous 48 h recruited by weekly 
frequency matching by geographical district of the household, age group, and enrolment week.
Findings Stool samples from 912 children with diarrhoea or dysentery and 706 controls from the case-control substudy 
were tested between Dec 22, 2016, and July 6, 2018. Estimated reference-standard cutoff values for cryptosporidiosis 
positivity were 2·3 × 10⁵ DNA copies per g of wet stool for qPCR, and 725 oocysts per g for qIFAT. LED-AP had a 
sensitivity for cryptosporidiosis of 88% (95% CI 79–94; 66 of 75 samples) and a specificity of 99% (98–99; 717 of 
726 samples); the lateral-flow test strip had a sensitivity of 89% (79–94; 63 of 71 samples) and a specificity of 99% (97–99; 
626 of 635 samples).
Interpretation LED-AP has high sensitivity and specificity for cryptosporidiosis and should be considered as a dual-
use technology that can be easily integrated with existing laboratory infrastructures in low-resource settings. 
The lateral-flow test strip has similar sensitivity and specificity and provides an alternative that does not require 
microscopy, although purchase cost of the test strip is unknown as it is not yet available on the market.
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staining microscopy.10 The Turkish study concluded, con-
curring with many previous reports, that modified Ziehl-
Neelsen staining microscopy is insuffi ciently accurate.5,11
In 2011, WHO recommended a large-scale shift in first-
line tuberculosis testing, to light-emitting diode fluores -
cence microscopy with auramine-phenol (AP) staining 
(LED-AP).12 Available at a reduced price to low-income 
countries, thousands of LED microscopes have been 
distributed in Ethiopia and other low-income or middle-
income countries (LMICs).13 AP microscopy, using 
traditional halogen-bulb fluorescence micro scopes, is well 
established as a diagnostic test for Cryptosporidium spp,11,14 
but its field performance in high-prevalence settings is 
largely unknown, with the exception of a small study in 
HIV-positive adults in India that reported high accuracy.15 
We found no studies that evaluated AP microscopy against 
the most accurate reference-standard tests (immuno-
fluorescence antibody test [IFAT] microscopy or quanti-
tative PCR [qPCR]) in children in an LMIC.
We hypothesised that LED-AP would have acceptable 
diagnostic accuracy (minimum sensitivity 70%, speci-
ficity 96%) and operational feasibility for cryptosporidiosis 
testing in children presenting to health-care facilities in a 
low-resource setting with high rates of malnutrition. As 
the most likely next-best alternative in centres without 
microscopy facilities, we included an ICLF in the 
evaluation; although ICLFs have variable performance in 
high-income countries,16–18 a few have shown promising 
results in LMICs.9,19,20 Most ICLFs require refrigeration; 
however, a lateral-flow test strip for Cryptosporidium spp 
that can be stored at room temperature has now been 
developed.20 We aimed to evaluate the diagnostic accuracy 
and operational feasibility of LED-AP and this lateral-flow 
test strip for cryptosporidiosis.
Few diagnostic accuracy studies and trials distinguish 
between Cryptosporidium spp infection and crypto spor-
idiosis, despite asymptomatic infections being well 
described for Cryptosporidium spp and other diarrhoeal 
Research in context
Evidence before this study
Cryptosporidium species are a common cause of watery 
childhood diarrhoea and an important cause of morbidity and 
mortality, particularly in sub-Saharan Africa. Current treatment 
for cryptosporidiosis is suboptimal, despite new drugs being in 
development, which emphasises the need for efficient and 
effective diagnostics. Most diagnostic tests in current use are 
either inaccurate or satisfy few of the commonly recommended 
criteria for an ideal diagnostic test for resource-limited settings. 
Targeted treatment strategies should be promoted on the basis 
of evidence of accuracy and operational performance from 
studies in representative clinical settings under field conditions.
We did a semisystematic review within PubMed using the search 
terms “cryptosporid*” AND (“test” OR “microscop*” OR “assay” 
OR “detect*”) AND (“accuracy” OR “sensitivity” OR “specificity” 
OR “diagnos*” OR “trial*”) AND (“diarrh*” OR “gastroenteritis” 
OR “gastrointestinal symptoms”) for articles in all languages, 
published from database inception to Jan 20, 2020, to identify 
studies on diagnostic accuracy for Cryptosporidium spp infection 
that included information on diarrhoeal symptoms with a 
minimum of 50 positive and 50 negative samples. We initially 
searched for prospective studies in consecutive series of children 
in low-income or middle-income countries (LMICs), as this is the 
recommended study design for external validity. Two studies 
were identified: one study from a middle-income country 
(Turkey) that reported 40% sensitivity of the traditional 
modified Ziehl-Neelsen staining microscopy method against 
ELISA, and one study from east Africa (Kenya and Malawi) 
that reported moderate sensitivity (43–77%) of three 
immunochromatographic lateral-flow (ICLF) tests against any 
detection by PCR—this was, however, a study in children with 
complicated severe acute malnutrition, and the estimates might 
not apply to the general paediatric population. Two studies from 
Bangladesh (one retrospective) reported good accuracy of ICLFs 
against diarrhoea attributed to Cryptosporidium spp by 
quantitative PCR; however, they used samples from a birth 
cohort study, with repeated samples, and their findings might 
not extrapolate to clinical settings.
A retrospective multicentre study from the UK reported 
92% sensitivity and 100% specificity of auramine-phenol (AP) 
staining against PCR and immunofluorescent antibody tests, 
but we identified no clinical diagnostic accuracy studies on the 
use of AP for cryptosporidiosis in children in LMICs. 
Furthermore, we did not find any field studies in LMICs that 
included data on operational issues, such as comprehensive 
cost calculations and test turnaround times.
Added value of this study
We evaluated the diagnostic accuracy of two simple tests 
(light-emitting diode fluorescence microscopy with AP staining 
[LED-AP] and a lateral-flow test strip) for cryptosporidiosis in 
children in a low-income country, and included cost-per-test 
calculations and operational assessment. Asymptomatic 
infections were controlled for by using quantitative reference 
methods. The sensitivity of LED-AP was consistent with 
estimates from a study in a high-income country, while 
maintaining high specificity. The lateral-flow test strip had 
similar sensitivity and specificity to LED-AP.
Implications of all the available evidence
Test-and-treat strategies for diarrhoea that include accurate 
detection of the aetiological agent will increase the chance of a 
useful clinical response. LED-AP is a reliable and affordable 
test for cryptosporidiosis that can be integrated with existing 
laboratory infrastructure, near the point of care, in LMICs. 
The lateral-flow test strip could be an alternative when LED-AP 
is unavailable, but is likely to be more expensive. Laboratories in 
LMICs that use modified Ziehl-Neelsen staining microscopy for 
Cryptosporidium spp testing could consider switching to LED-AP.
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pathogens. Simply detecting a pathogen will have 
reduced value when the purpose of testing is to select 
those patients for whom intervention might be of 
clinical value. Building on studies where quantitative 
testing in both cases of cryptosporidiosis and commu-
nity controls has been applied to discriminate between 
asymptomatic and symptomatic infection,2,21,22 we chose 
a panel of reference tests that included two different 
quantitative assays. We embedded a case-control study 
in the accuracy study to estimate quantitative cutoff 
values, and to allow estimation of the predictive value of 
LED-AP and the ICLF test strip for clinical disease in 
our study population.
Methods
Study design and participants
We did a prospective diagnostic accuracy study for 
cryptosporidiosis in children presenting to health-care 
facilities with diarrhoea or dysentery, in Jimma 
Medical Centre, Jimma, and Serbo Health Centre, 
Serbo, in southwest Ethiopia. Jimma Medical Centre is 
a tertiary referral hospital located in an urban area; 
Serbo Health Centre covers a rural area around the 
smaller town of Serbo, approximately 16 km from 
Jimma.
Study nurses screened children younger than 5 years 
of age at the paediatric outpatient departments and all 
inpatient wards at both centres for eligibility. Children 
were consecutively enrolled from 0800 h to 1800 h 
every day at Jimma Medical Centre and from 0800 h 
to 1700 h in Serbo Health Centre. Children were 
eligible if they had diarrhoea (three or more loose 
stools within the previous 24 h) or dysentery (at least 
one loose stool with stains of blood within the previous 
24 h), regardless of whether these were the primary 
complaints leading them to seek health care. The 
exclusion criterion was inpatient admission for longer 
than 24 h before enrol ment in the study. Written 
informed consent was obtained from the children’s 
caregivers and we followed STARD guidelines.8
The embedded case-control study included children 
with diarrhoea from the 15 districts in and around 
Jimma and the eight districts surrounding Serbo. 
Community controls without diarrhoea in the previous 
48 h were recruited by weekly frequency matching by 
geographical district of the household, age group, and 
enrolment week.23
Jimma University Institutional Review Board 
(reference RPGC/610/2016), the Ethiopian National 
Research Ethics Review Committee (reference JU 
JURPGD/839/2017), and the Regional Committee for 
Medical and Health Research Ethics of Western 
Norway (reference 2016/1096) approved the study.
Procedures
Study nurses collected demographic and clinical data 
using standardised case-report forms. Information about 
treatment and clinical outcome was collected by interview 
with caregivers and from hospital records. All participants 
were tested for HIV (appendix 2 p 2), where possible, and 
were asked to provide a stool sample. Stool was collected 
using a nappy, single-use bedpan, or potty, and quickly 
transferred to a screw-cap plastic container. Study nurses 
lined nappies with plastic film to avoid water absorption 
from the stool into the absorbent polymer layer of 
the nappy. Samples were stored at 4°C until further 
processing.
All laboratory personnel that performed index and 
reference testing were fully masked to results of the other 
tests and to clinical information, including case or control 
status (ie, diarrhoea or no diarrhoea) of the participants. 
LED-AP testing was done by medical laboratory technicians 
trained in the method accord ing to a described standardised 
operating procedure (appendix 2 p 16) in addition to their 
routine laboratory duties. AP staining was done on a 
manually homogenised, air-dried stool smear, without 
preceding sample concen tration. The reagents used were 
the same as those used for auramine staining of sputum 
smears for acid-fast bacilli, but with a standard operating 
procedure opti mised for detecting Cryptosporidium spp 
oocysts. AP-stained slides were examined using a 
PrimoStar iLED fluorescence microscope (Carl Zeiss 
Microscopy, Jena, Germany) for objects of the same size 
and morphology as Cryptosporidium spp oocysts (figure 1) 
and were cate gorised according to average number of 
oocysts per 200 × magnification field of view: one to nine, 
ten to 50, or more than 50 (appendix 2 pp 2, 17).
Findings were reported on a standardised results form. 
Microscopy slides were kept at ambient temperature in a 
closed, non-transparent box. Once per month, the study 
investigator (ØHJ) selected ten slides for blinded review 
and to assess microscope settings and the quality of 
stains (appendix 2 pp 21–22); result discrepancies did not 
affect the recorded results of LED-AP testing, but were 
used as a basis for immediate feedback and on-site 
retraining for laboratory technicians.
See Online for appendix 2
Figure 1: Auramine-phenol stained Cryptosporidium spp oocysts (diameter 
4–6 µm), displaying characteristic erythrocyte pattern of staining
Section of 400 × magnification field (LJR, personal photograph).
10 µm
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Figure 2: Study flowchart
LED-AP=light-emitting diode fluorescence microscopy with auramine-phenol (AP) staining.
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 4 two reference
  tests missing,
  and sample lost
 2 two reference
  tests missing,
  not sent for PCR 
  by mistake
 1 all reference
  tests missing,
  and sample lost
 1 one reference test
  missing, others
  with discrepant
  results
34 samples not tested by LED-AP
 19 due to study disruptions
 8 mislabelled or lost
 7 record missing or not done
152 samples not tested by lateral-flow test strip
 119 record missing or not done
 30 mislabelled or lost
 3 insufficient amount of sample
1406 eligible children identified
494 excluded
 472 did not submit stool sample
 22 not enrolled due to work overload
1475 children screened
69 excluded
 48 did not consent to participate
 10 had been inpatient for longer than 24 h
 8 no longer fulfilled inclusion criteria at enrolment
 2 caregiver younger than 18 years of age
 1 other
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Cryptosporidium EZ VUE lateral-flow test strips 
(TECHLAB, Blacksburg, VA, USA) were used for rapid 
testing for Cryptosporidium spp antigen (appendix 2 p 3). 
Lateral-flow strip testing was done by laboratory 
technicians other than those who did LED-AP testing 
and was done at the Jimma Medical Centre laboratory, 
twice per week.
As there is no commonly accepted reference-standard 
test for asymptomatic or symptomatic Cryptosporidium 
spp infections, we used a composite reference panel 
that included quantitative IFAT (qIFAT) for detection 
of Cryptosporidium spp oocysts, ELISA for detection of 
Cryptosporidium spp antigen, and qPCR for detection of 
Cryptosporidium spp DNA (appendix 2 p 3). Quantitative 
cutoff values for the association of Cryptosporidium spp 
detection with diarrhoea were defined as the qPCR and 
qIFAT quantity that maximally discriminated case or 
control status in the case-control substudy and were given 
as target DNA copy number (qPCR) or oocysts (qIFAT) 
per g of wet stool.
Positive microbiological composite reference standard 
(MRS) was defined as two or more positive reference tests 
and negative MRS as two or more negative reference tests. 
Positive clinical composite reference standard (CRS) was 
defined as two or more positive reference tests (and 
greater than the quantitative cutoff value for association 
with diarrhoea) and negative CRS as two or more negative 
reference tests (or less than the quantitative cutoff value 
for association with diarrhoea). Cryptosporidium spp infec-
tion was defined as a diarrhoea case or non-diarrhoea 
control with positive MRS. Cryptosporidiosis was defined 
as a diarrhoea case with positive CRS.
Operational data were also collected and these included 
test turnaround times, cost of reagents and laboratory 
expendables used for LED-AP and ICLF strip testing, 
standardised report forms from supervision visits to both 
enrolment sites, and reports on internal quality assess-
ment at both sites.
Statistical analysis
For the diagnostic accuracy sample-size calculations, we 
assumed that the main limiting factor would be sensitivity, 
as its precision would depend on the number of children 
with cryptosporidiosis that we recruited into the study. With 
a margin of error of 10%, a power of 90%, and an assumed 
minimum acceptable sensitivity of 70% for a cryptos-
poridiosis test to be cost-effective,24 we estimated that a 
minimum of 75 children with cryptosporidiosis should be 
enrolled to achieve the necessary precision in sensitivity. 
Double data entry was done with EpiData (version 3.1). All 
data analyses were done using R (version 3.5.2). 95% CIs 
were used to represent statistical precision and a p value of 
less than 0·05 was considered significant.
Quantitative cutoff values designed to maximise 
discrimination between cases and controls were estab-
lished for Cryptosporidium spp qPCR and qIFAT by 
analysis of all PCR and IFAT-positive cases and controls 
in the substudy, using a receiver operating characteristic 
curve analysis with pathogen quantity in stool as the 
discrim inating variable and case or control status as the 
dependent variable (appendix 2 p 7).
Difference in average Cryptosporidium spp quantity 
(DNA copies per g of stool for qPCR and oocysts per g for 
qIFAT) between case and control samples was assessed by 
comparing mean averages in an unpaired Welch two-
sample t test; if distributions were positively skewed, we 
used log transformation before the t test to achieve 
normality.
95% CIs for test sensitivity, specificity, and positive and 
negative predictive values were calculated by the Wilson 
method,25 and for positive and negative likelihood ratios 
with formulae from Simel and colleagues.26 The strength 
of association between Cryptosporidium spp detection and 
diarrhoea was approximated by the odds ratio in the case-
control substudy. Spearman’s rank correlation was used 
to quantify the association between semiquantitative 
scoring of positive AP slides (ie, one to nine, ten to 50, or 
more than 50 oocysts per magnification field of view) 
with quantitative results obtained by qPCR and qIFAT.
Role of the funding source
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and final responsibility 
for the decision to submit for publication.
Participants
Age in months, median (IQR) 12 (8–22)
Female sex 379/912 (42%)
Diarrhoea episode
Duration in days, median (IQR) 3 (2–5)*
Acute episode (1–6 days) 745/907 (82%)
Prolonged episode (7–13 days) 116/907 (13%)
Persistent episode (14 days or longer) 46/907 (5%)
Moderate-to-severe diarrhoea 190/782 (24%)
Dysentery (visible blood in stool)
By caregiver report 78/910 (9%)
By caregiver report or by laboratory technician 
inspection of stool†
92/910 (10%)
Severe acute malnutrition 86/911 (9%)
Stunted growth 200/907 (22%)
HIV positive 2/682 (<1%)
HIV exposed 2/682 (<1%)
Rotavirus vaccination 853/910 (94%)
Enrolment site Jimma Medical Centre 445/912 (49%)
Enrolment site Serbo Health Centre 467/912 (51%)
Data are n/N (%) unless otherwise stated. Denominators vary because of missing 
data for some participants (eg, not recorded or not answered). *N=907. †By gross 
inspection of the sample after it arrived in the clinical laboratory (data available 
from 637 samples).
Table 1: Demographic and clinical characteristics of children with 
diarrhoea in the diagnostic accuracy study
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Results
From Dec 22, 2016, to July 6, 2018, 1475 children with 
diarrhoea or dysentery were screened, 1384 were enrolled 
and, of these, 912 provided a stool sample (figure 2; 
table 1). All children who fulfilled the dysentery definition 
also fulfilled the diarrhoea definition. The case-control 
substudy23 enrolled 1134 children with diarrhoea (with 
749 stool samples) and 946 controls (706 stool samples; 
appendix 2 pp 5–6).
Cryptosporidium spp were significantly associated 
with diarrhoea with all detection methods used, but 
the strength of the association varied by test modality 
(table 2). When comparing Cryptosporidium spp quanti-
ties in case and control samples from the substudy, the 
median PCR quantity was 4·7 × 10⁵ DNA copies per g 
of stool (IQR 0·7–36·8 × 10⁵) in case samples and 
1·2 × 10⁵ DNA copies per g (0·2–10·2 × 10⁵) in control 
samples. The PCR quantity ratio of geometric means in 
case stools to control stools was 3·8 (95% CI 1·5–9·8). 
The ratio was similar for IFAT quantification (3·3; 95% CI 
1·8–6·1; appendix 2 pp 8–9). After estimating qPCR and 
qIFAT quantitative cutoff values (appendix 2 p 7) we 
applied the clinical composite reference standard to 
classify cases as cryptosporidiosis or non-cryptosporidiosis 
for the diag nostic accuracy calculations. 77 (9%) of 
878 samples tested with LED-AP and 54 (7%) of 
760 samples tested with the lateral-flow test strip had 
incomplete or missing reference-standard results and 
were excluded from further analysis (figure 2).
Of the 77 children with cryptosporidiosis, 25 (38%) 
of 66 children (clinical outcome data missing for 11) 
had moderate-to-severe diarrhoea (appendix 2 p 4) and of 
the 745 cases without crypto sporidiosis, 149 (23%) 
of 638 children (data missing for 107) had moderate-to-
severe diarrhoea. On enrolment of children both with 
and without crypto sporidiosis, the median diarrhoea 
duration was 3 days (IQR 3–7 for children with crypto-
sporidiosis and 2–4 days for children without). Severe 
acute malnutrition (appendix 2 p 4) was diagnosed in 
nine (12%) of 77 children with cryptosporidiosis and 
69 (9%) of 744 children without cryptosporidiosis.
In the primary analysis, LED-AP had a sensitivity for 
cryptosporidiosis of 88% (95% CI 79–94; 66 of 75 samples) 
and a specificity of 99% (98–99; 717 of 726 samples). The 
lateral-flow test strip had a sensitivity of 89% (79–94; 
63 of 71 samples) and a specificity of 99% (97–99; 626 of 
635 samples; table 3).
An exploratory comparison of LED-AP and the lateral-
flow test strip showed no significant differences in 
sensitivity, specificity, or predictive values between the 
two diagnostic tests (appendix 2 p 11). We observed a 
higher prevalence of cryptosporidiosis at the Jimma 
enrolment site than at the Serbo site, but adjusting the 
positive and negative predictive values for local prevalence 
had little effect on the estimates (appendix 2 p 11).
There was a positive correlation between semi quanti-
tative grading of LED-AP slides (ie, one to nine, ten to 50, 
or more than 50 oocysts per magnification field of view) 
and quantitative results from qIFAT (Spearman’s ρ 0·32, 
p=0·010) and qPCR (Spearman’s ρ 0·27, p=0·011). The 
weakest IFAT-positive sample had only three oocysts in 
the IFAT sample well (approximately 75 oocysts per g of 
stool) and this sample was also positive by both LED-AP 
and the lateral-flow test strip. The lowest Cryptosporidium 
spp PCR quantity that was also positive by LED-AP 
was 13 836 DNA copies per g of stool; this was also the 
lowest PCR quantity that was positive by the lateral-flow 
test strip. Most PCR-positive samples that were negative 
by LED-AP and the test strip had low quantities of 
Cryptosporidium spp DNA (figure 3). Most false-negative 
index test results were in the lower range of positive by 
PCR, and there seemed to be a negative relationship 
Positive test in cases 
of diarrhoea, n/N (%)
Positive test in controls, 
n/N (%)
Odds ratio of positive 
test for diarrhoea 
(95% CI)*
Index tests
LED-AP 66/717 (9%) 11/689 (2%) 6·25 (3·27–11·94)
Lateral-flow test strip 67/620 (11%) 13/563 (2%) 5·13 (2·80–9·39)
Reference tests
ELISA 69/666 (10%) 12/680 (2%) 6·43 (3·45–11·99)
PCR (any detection) 104/652 (16%) 45/668 (7%) 2·64 (1·82–3·81)
qPCR (above cutoff) 67/652 (10%) 15/670 (2%) 5·00 (2·83–8·85)
IFAT (any detection) 72/681 (11%) 25/668 (4%) 3·04 (1·90–4·86)
qIFAT (above cutoff) 48/680 (7%) 7/668 (1%) 7·17 (3·22–15·97)
Reference panels
MRS 66/669 (10%) 14/676 (2%) 5·18 (2·88–9·31)
CRS 62/669 (9%) 8/677 (1%) 8·54 (4·06–17·98)
Denominators vary because of missing data for some participants (eg, not recorded or not answered). 
LED-AP=light-emitting diode fluorescence microscopy with auramine-phenol (AP) staining. qPCR=quantitative PCR. 
IFAT=immunofluorescent antibody test. qIFAT=quantitative IFAT. MRS=microbiological composite reference standard. 
CRS=clinical composite reference standard. *Wald intervals.
Table 2: The association between various Cryptosporidium spp detection methods and diarrhoea in the 
case-control substudy




9% (8–12) 10% (8–13)
Sensitivity 88% (79–94) 89% (79–94)
Specificity 99% (98–99) 99% (97–99)
Positive predictive value 88% (79–94) 87·5% (78–93)
Negative predictive value 99% (98–99) 99% (98–99)
Likelihood ratio of a 
positive test
71·0 (36·9–136·3) 62·6 (32·6–120·4)
Likelihood ratio of a 
negative test
0·1 (0·1–0·2) 0·1 (0·1–0·2)
Data are point estimates with 95% CI. Cryptosporidiosis was defined as a case of 
diarrhoea with a positive clinical composite reference standard. Absolute numbers 
are shown in the appendix (p 10). LED-AP=light-emitting diode fluorescence 
microscopy with auramine-phenol (AP) staining.
Table 3: Diagnostic accuracy of LED-AP and lateral-flow test strip for 
cryptosporidiosis
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between laboratory technician experience and false-
negative test results (data not shown).
We did an exploratory analysis of the diagnostic accuracy 
of the index tests for asymptomatic infection by cross-
tabulating LED-AP by the microbiological composite 
reference standard in controls with no diarrhoea. For 
asymptomatic infection, LED-AP had a sensitivity of 64% 
and a specificity of greater than 99%, and the lateral-flow 
test strip had a sensitivity of 79% and a specificity of 
greater than 99%, but these estimates had wide margins 
of uncertainty (appendix 2 p 11).
For turnaround time calculations, we used available data 
from LED-AP tests done on both case (n=878) and control 
(n=689) samples (n=1567; appendix 2 p 5). LED-AP was 
done on the day of stool collection in 1104 (77%) 
of 1431 tests, the following day in 309 tests (22%), and 2 or 
more days later in 18 tests (1%; data missing for 136). 
Total test turnaround time (ie, time from when the 
sample was obtained until the result was received) 
was available from 1322 (84%) of 1567 tests; of these, 
607 results (46%) came back on the day the sample 
was obtained, 545 (41%) the following day, and the 
remaining 170 (13%) came back after 2 or more days. For 
results received the same day, test turnaround time 
ranged from 0·5 h to 7·8 h (median 3·5; IQR 1·7–4·9); a 
breakdown of turnaround times into subphases showed 
that median duration of preanalytical and postanalytical 
phases comprised the major fraction of total turnaround 
time (appendix 2 p 12).
Several operational issues relevant to implementation 
of LED-AP testing in routine care were identified during 
the study (appendix 2 p 13). The overall response of 
the clinical laboratory technicians after commencing 
AP staining for Cryptosporidium spp was encouraging, 
and they reported that operation and maintenance of the 
LED microscope was easier than or similar to that 
of conven tional microscopes already in use. A specific 
benefit of the PrimoStar iLED microscope was the ease 
of switching between fluorescence and conventional 
light microscopy operation. A cost-per-test analysis, 
assuming expendables are purchased in bulk for 
approximately 500 tests, also factoring in labour time, 
estimated a cost of US$0·7 per LED-AP test, and $0·6 per 
lateral-flow strip test (excluding the cost of the test strip 
itself, as it is currently not yet available for purchase; 
appendix 2 pp 14–15).
Discussion
We evaluated two tests suitable for near-patient use in 
children with community-acquired diarrhoea in a low-
resource setting. In our combined population, children 
testing positive for Cryptosporidium spp by LED-AP or 
the lateral-flow test strip had 88% probability of 
having cryptosporidiosis, and those testing negative had 
99% probability of not having cryptosporidiosis. Our 
study is the first adequately powered prospective diag-
nostic accuracy study for cryptosporidiosis in a consec-
utive series of children presenting to health-care facilities 
with diarrhoea in an LMIC. Testing was done by tech-
nicians who had received basic training and super vision, 
using the most widespread LED microscope in current 
use, and we found diagnostic accuracy consistent with 
estimates from a retrospective accuracy study in a high-
income country.11 The Cryptosporidium EZ VUE lateral-
flow test strips were easy to use and were as accurate as 
LED-AP, and have the advantage, by contrast with most 
ICLFs, that they do not require refrigeration.
We aimed for a representative sample by using broad 
inclusion criteria for all children aged younger than 5 years 
of age who presented with diarrhoea, by pros pective enrol-
ment irrespective of presenting complaint, and without 
excluding important and vulnerable sub groups, such as 
children with severe acute malnutrition or diarrhoea of 
prolonged duration. Test inter pretation bias was addressed 
by full masking of technicians, and by applying the 
reference standard to all patients, irres pective of index test 
results.
Our study was insufficiently powered to estimate 
diagnostic accuracy for asymptomatic infection; these 
estimates therefore have a wide margin of uncertainty but 
indicate low sensitivity. Both tests failed to detect many 
only qPCR-positive samples from asymptomatic children, 
but we consider this finding as an advantage from a clinical 
point of view. Many low-level Cryptosporidium spp 
detections on qPCR in children with diarrhoea can pro-
bably be explained by diarrhoea from other infectious or 
non-infectious causes, combined with incidental detection 
of Cryptosporidium spp DNA. These detections could be 
explained by various reasons other than clinical infection: 
asymptomatic carriage, postinfectious shedding, or inges-
Figure 3: Cryptosporidium spp DNA quantity distribution
Data from 127 diarrhoea cases and 37 diarrhoea-free controls; PCR quantity 
missing for two samples with positive microbiological composite reference 


















25 Index test results
 Both negative
 Only lateral-flow test strip positive
 Only LED-AP positive
 Both positive
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tion of oocysts that are no longer infectious or are from a 
Cryptosporidium species that does not infect humans. The 
main purpose of a test-and-treat strategy should be to 
detect the most likely causative agent of a diarrhoeal 
episode and thereby increase the chance of a useful 
clinical response. For the purpose of clinical drug trials 
for cryptosporidiosis, finding the right balance between 
sensitivity and specificity will increase the power to detect 
a clinical effect.
A range of factors should be considered when inter-
preting our findings. First, the study was deliberately done 
in an area of low HIV prevalence; however, as crypto-
sporidiosis is more common and severe in patients with 
impaired cellular immunity, the accuracy or predictive 
values of the tests might not be repre sentative of settings 
with high prevalence of untreated HIV disease in 
children. Similarly, pretest and post-test probabilities for 
cryptosporidiosis might differ in vulnerable subgroups of 
children (eg, with prolonged or persistent diarrhoea, acute 
mal nutrition, or severe diarrhoea), but we did not examine 
this in our study.
Second, missing composite reference-standard results 
for both LED-AP and the lateral-flow strip tests were 
somewhat higher than expected and, although the 
breakdown of reasons for missing tests (figure 2) indicate 
reasons unlikely to bias the accuracy estimates, missing-at-
near-random is still an underlying assumption that 
warrants caution.
Third, we did not include tests for other diarrhoeal 
pathogens in this study because of cost constraints, which 
could lead to misclassification of some diarrhoeal episodes 
that were due to pathogens other than Cryptosporidium 
spp. Such misclassification could lead to bias and 
overestimation of specificity and positive predictive values. 
However, this bias would have a small effect, as there were 
few positive detections, and because previous reports 
indicate most high-quantity Crypto sporidium spp detections 
to be associated with diarrhoea, even when in mixed 
infections.2,27 Detections of other acid-fast oocysts on 
LED-AP (eg, Cystoisospora belli, Cyclospora cayetanensis) 
occurred too infrequently to have any role (data not 
reported here).
Fourth, when estimating quantitative cutoff values for 
qIFAT and qPCR in the case-control substudy, we could 
not distinguish between new asymptomatic infections and 
shedding associated with a previous diarrhoeal episode. 
Although diarrhoea within the last month was reported for 
some children, the proportion was similar in cases and 
controls (appendix 2 p 6). Some epidemiological studies 
require a longer diarrhoea-free period for controls, but, in 
our opinion, the same criteria should apply to cases and 
controls. By using a short diarrhoea-free period (48 h), we 
increased the clinical validity of the quantitative cutoff 
values, and avoided excluding an important subgroup of 
cases from the study.
Fifth, the long test turnaround time for some samples 
could be a challenge for implementation but might, in 
part, be a study effect, because treatment was unavailable; 
ideally this should be re-evaluated as part of a test-and-
treatment trial. Furthermore, test strip turnaround time 
was not measured, due to personnel constraints, but its 
hands-on time was similar to LED-AP. Considering the 
short hands-on time of LED-AP, the in-laboratory fraction 
of test turnaround time was large, but a much smaller 
contributor than the preanalytical and postanalytical 
phases. This breakdown of turnaround time is likely to 
reflect challenges in com munication between laboratory 
and clinical personnel, and with sample transport. 
Preanalytical and post analytical contributions to test 
turnaround time would need to be addressed before 
scaling up testing.
Lastly, as accuracies of specific ICLF kits vary 
considerably,16–18 we advise caution against extrapolating 
the accuracy estimates for the lateral-flow test strip to other 
ICLFs.
The minimum essential cost of any new crypto spori-
diosis drug has been suggested as $2·0 per treatment 
course.28 The cost of diagnostics should be added to this, as 
empirical therapy would lead to unacceptably high rates of 
unnecessary treatment. In our setup, the added cost of 
testing amounted to about $0·7 per test for LED-AP, and 
considerably more for the rapid lateral-flow test strip when 
including the cost of the test strip itself. Although these 
cost estimates are well below the estimated cost for each 
cryptosporidiosis episode in LMICs,29 our results indicate 
that a compre hensive cost-effectiveness evaluation and an 
under standing of the local so-called diagnostic ecosystem 
would be required before large-scale rollout of either test.30
In conclusion, our results show that both LED-AP and 
the Cryptosporidium EZ VUE lateral-flow test strip have 
high diagnostic accuracy and operational features suitable 
for inclusion in test-and-treat interventions for cryptos-
poridiosis. Where LED microscopes are already available, 
LED-AP testing seems the more affordable, easy-to-
implement, and sustainable option.
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